Close Menu

Takara Bio

This story has been updated from a previous version to include information about the agreement between TATAA Biocenter and Roche.

The headline of this article has been changed from a previous version to clarify Takara Bio Europe's sales strategy.
By Ben Butkus

WaferGen Biosystems said this week that Scott Davidson and Joseph Pesce have joined the company's board of directors.

Eppendorf said this week that it has licensed patents covering gradient technology for thermal cyclers to Takara Bio.

Takara Bio has been awarded US Patent No. 8,048,987, "Polypeptides having DNA polymerase activity."
Yoshimi Sato, Kazue Nishiwaki, Nana Shimada, Shigekazu Hokazono, Takashi Uemori, Hiroyuki Mukai, and Ikunoshin Kato are named as inventors on the patent.

Pages

NPR reports that the patient who underwent a CRISPR-based treatment for sickle cell disease is doing well.

Resistance to ash dieback disease among some UK ash trees appears polygenic, the Independent reports.

In Nucleic Acids Research this week: sequencing strategy for flash-frozen brain tissue bank samples, new version of ChlamDB, and more.

A UK woman is suing three National Health Service Trusts for not telling her about her father's Huntington's disease diagnosis, the BBC reports.